Astrazeneca (AZN) EPS (Weighted Average and Diluted) Growth (5y) (2014 - 2025)

Astrazeneca (AZN) EPS (Weighted Average and Diluted) Growth (5y) (2014 - 2025) Analysis & Trends

Generated on {Timestamp} © BusinessQuant.com
Generated on {Timestamp} Powered by BusinessQuant Logo

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Gsk 92,316,836.42 Bn 92,316,831.46 Bn 7.76 Bn
2 Eli Lilly 983.57 Bn 978.29 Bn 16.22 Bn
3 Johnson & Johnson 553.56 Bn 531.50 Bn 15.96 Bn
4 AbbVie 383.35 Bn 374.00 Bn 10.78 Bn
5 Merck 281.71 Bn 276.06 Bn 12.09 Bn
6 Amgen 182.20 Bn 170.16 Bn 5.87 Bn
7 Gilead Sciences 153.71 Bn 145.98 Bn 5.52 Bn
8 Pfizer 143.75 Bn 130.98 Bn -1.21 Bn
9 Bristol Myers Squibb 109.71 Bn 99.25 Bn 8.07 Bn
10 Astrazeneca 67.83 Bn 59.89 Bn 12.61 Bn

Historic Data

Download Data
DateValue
Dec 31, 2025 20.02%
Sep 30, 2025 27.02%
Jun 30, 2025 22.04%
Dec 31, 2024 39.49%
Sep 30, 2024 39.18%
Jun 30, 2024 75.38%
Mar 31, 2024 24.40%
Dec 31, 2023 -5.44%
Sep 30, 2023 27.61%
Jun 30, 2023 41.09%
Dec 31, 2022 -6.48%
Jun 30, 2022 -4.04%
Dec 31, 2021 -27.35%
Sep 30, 2021 12.38%
Mar 31, 2021 20.20%
Dec 31, 2020 -1.03%
Sep 30, 2020 1.30%
Jun 30, 2020 1.07%
Mar 31, 2020 4.34%
Dec 31, 2019 14.87%